Newsfeeds - Spark Newswire

3 minute read

31 Stocks Moving In Monday’s Mid-Day Session

Today, 10:13 AM

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission.

APOP

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 27, 2021

By Benzinga Insights

Today, 10:13 AM

ABNB

1 minute read

Roth Capital Upgrades Seelos Therapeutics to Buy, Raises Price Target to $8

By vishwanath@benzinga.com

Today, 10:13 AM

Roth Capital analyst Jonathan Aschoff upgrades Seelos Therapeutics (NASDAQ:SEEL) from Neutral to Buy and raises the price target from $2.5 to $8.

SEEL

1 minute read

Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial

By Vandana Singh

Today, 10:13 AM

The Sean M. Healey & AMG Center for ALS at Mass General received approval from the FDA and the Mass…

SEEL

1 minute read

News

Why Seelos Therapeutics’ Stock Is Trading Higher Today

By Benzinga Insights

Today, 10:13 AM

Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (Trehalose) receives "May Proceed" notice and Central IRB approval for the HEALEY ALS Platform Trial.'

SEEL

1 minute read

News

Why Seelos Therapeutics’ Stock Is Trading Higher Today

By Benzinga Insights

Today, 10:13 AM

SEEL

1 minute read

Seelos Therapeutics Shares Spike Higher; Traders Circulate Massachusetts General Hospital Report Titled ‘Investigational drug SLS-005 (Trehalose) receives “May Proceed” notice and Central IRB approval for the HEALEY ALS Platform Trial’

By Benzinga Newsdesk

Today, 10:13 AM

https://www.massgeneral.org/news/press-release/Investigational-drug-receives-may-proceed-notice-for-healey-als-trial

SEEL

1 minute read

Seelos Therapeutics Shares Spike Higher; Traders Circulate Massachusetts General Hospital Report Titled ‘Investigational drug SLS-005 (Trehalose) receives “May Proceed” notice and Central IRB approval for the HEALEY ALS Platform Trial’

By 8

Today, 10:13 AM

https://www.massgeneral.org/news/press-release/Investigational-drug-receives-may-proceed-notice-for-healey-als-trial

SEEL

1 minute read

WAVE Life Sciences, Seelos Therapeutics Shares Up ~11% Following Earlier STAT News Article ‘Facing pressure from ALS patients and advocates, the FDA does about-face on review of potential treatment’

By Benzinga Newsdesk

Today, 10:13 AM

https://www.statnews.com/2021/09/15/facing-pressure-from-als-patients-and-advocates-the-fda-does-about-face-on-review-of-potential-treatment/

SEEL

7 minute read

Meet The Top 12 CEOs In The Psychedelics Industry

By Natan Ponieman

Today, 10:13 AM

By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.

ATAI